A phase III multicentre, double-blind, placebo-controlled study (TANGO) to evaluate CER-001 on carotid atherosclerosis (vessel wall area) in patients with familial primary hypoalphalipoproteinaemia. (September 2016) - Stroes, E.; Benghozi, R.; Dasseux, J.L.; Genest, J.; Ginsberg, H.; Keyserling, C.; Leitersdorf, E.; Raggi, P.; von Eckardstein, A.